Borgestad Valuation
Is H46 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of H46 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: H46 (€0.02) is trading below our estimate of fair value (€0.93)
Significantly Below Fair Value: H46 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for H46?
Key metric: As H46 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is H46's PS Ratio? | |
|---|---|
| PS Ratio | 0.5x |
| Sales | NOK 1.11b |
| Market Cap | NOK 583.78m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 10.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does H46's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
STO3 Sto SE KGaA | 0.4x | 1.8% | €736.4m |
BNN BRAIN Biotech | 1.2x | 8.5% | €69.9m |
IBU IBU-tec advanced materials | 0.6x | 19.2% | €29.0m |
DLX Delignit | 0.3x | 10.2% | €22.3m |
H46 Borgestad | 0.5x | 3.6% | €583.8m |
Price-To-Sales vs Peers: H46 is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does H46's PS Ratio compare vs other companies in the European Basic Materials Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: H46 is good value based on its Price-To-Sales Ratio (0.5x) compared to the European Basic Materials industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is H46's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.5x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate H46's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Compañía de Minas BuenaventuraA
US$3.0b
Engages in the exploration, development, construction, and operation of mineral processing business.
MBU
US$11.40
7D
-1.7%
1Y
36.5%
Mitsubishi Chemical Group
JP¥1.2t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥5.05
7D
0.9%
1Y
-12.1%
African Rainbow Minerals
R31.4b
Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.
EB9
R8.40
7D
-1.8%
1Y
-3.4%